ES2865124T3 - Procedimiento en una etapa para la purificación de ácidos nuncleicos - Google Patents
Procedimiento en una etapa para la purificación de ácidos nuncleicos Download PDFInfo
- Publication number
- ES2865124T3 ES2865124T3 ES14765295T ES14765295T ES2865124T3 ES 2865124 T3 ES2865124 T3 ES 2865124T3 ES 14765295 T ES14765295 T ES 14765295T ES 14765295 T ES14765295 T ES 14765295T ES 2865124 T3 ES2865124 T3 ES 2865124T3
- Authority
- ES
- Spain
- Prior art keywords
- nucleic acids
- sample
- solid substrate
- gel
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 103
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 102
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 102
- 238000000746 purification Methods 0.000 title description 6
- 238000010915 one-step procedure Methods 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 60
- 239000000758 substrate Substances 0.000 claims abstract description 43
- 239000007787 solid Substances 0.000 claims abstract description 38
- 239000012149 elution buffer Substances 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000012139 lysis buffer Substances 0.000 claims abstract description 31
- 230000005291 magnetic effect Effects 0.000 claims abstract description 27
- 239000011859 microparticle Substances 0.000 claims abstract description 20
- 238000003556 assay Methods 0.000 claims abstract description 11
- 238000000926 separation method Methods 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 27
- 150000003839 salts Chemical class 0.000 claims description 15
- 239000003960 organic solvent Substances 0.000 claims description 8
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 6
- 108091023037 Aptamer Proteins 0.000 claims description 3
- 108090001008 Avidin Proteins 0.000 claims description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 3
- 102100034343 Integrase Human genes 0.000 claims description 3
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 3
- 108010090804 Streptavidin Proteins 0.000 claims description 3
- 239000011616 biotin Substances 0.000 claims description 3
- 229960002685 biotin Drugs 0.000 claims description 3
- 235000020958 biotin Nutrition 0.000 claims description 3
- 230000004049 epigenetic modification Effects 0.000 claims description 3
- 238000007899 nucleic acid hybridization Methods 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 2
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 239000000499 gel Substances 0.000 description 71
- 239000000523 sample Substances 0.000 description 47
- 239000002245 particle Substances 0.000 description 46
- 239000006249 magnetic particle Substances 0.000 description 23
- 239000000243 solution Substances 0.000 description 22
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 17
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 17
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 17
- 230000009089 cytolysis Effects 0.000 description 16
- 229920000936 Agarose Polymers 0.000 description 14
- 239000000203 mixture Substances 0.000 description 13
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 10
- 238000005406 washing Methods 0.000 description 10
- 239000000356 contaminant Substances 0.000 description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 238000002955 isolation Methods 0.000 description 7
- 239000011159 matrix material Substances 0.000 description 7
- 239000000377 silicon dioxide Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 238000010828 elution Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000000872 buffer Substances 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 238000001821 nucleic acid purification Methods 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- -1 polypropylene Polymers 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- 102000016911 Deoxyribonucleases Human genes 0.000 description 2
- 108010053770 Deoxyribonucleases Proteins 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- 108020004566 Transfer RNA Proteins 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 108020004418 ribosomal RNA Proteins 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 241000711549 Hepacivirus C Species 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 238000002944 PCR assay Methods 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000009412 basement excavation Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000003196 chaotropic effect Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229940009976 deoxycholate Drugs 0.000 description 1
- 229960003964 deoxycholic acid Drugs 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000009144 enzymatic modification Effects 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-O guanidinium Chemical compound NC(N)=[NH2+] ZRALSGWEFCBTJO-UHFFFAOYSA-O 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000000464 low-speed centrifugation Methods 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002159 nanocrystal Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229940068965 polysorbates Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000013014 purified material Substances 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 229940083575 sodium dodecyl sulfate Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 239000013026 undiluted sample Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
- C12N15/1013—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by using magnetic beads
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Virology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361789622P | 2013-03-15 | 2013-03-15 | |
| PCT/US2014/028518 WO2014144209A1 (en) | 2013-03-15 | 2014-03-14 | One-step procedure for the purification of nucleic acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2865124T3 true ES2865124T3 (es) | 2021-10-15 |
Family
ID=51528702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES14765295T Active ES2865124T3 (es) | 2013-03-15 | 2014-03-14 | Procedimiento en una etapa para la purificación de ácidos nuncleicos |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9803230B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3828284A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6431522B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN105120986B (cg-RX-API-DMAC7.html) |
| ES (1) | ES2865124T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014144209A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3828284A1 (en) * | 2013-03-15 | 2021-06-02 | Abbott Molecular Inc. | One-step procedure for the purification of nucleic acids |
| US10392613B2 (en) | 2015-07-14 | 2019-08-27 | Abbott Molecular Inc. | Purification of nucleic acids using copper-titanium oxides |
| JPWO2017043649A1 (ja) * | 2015-09-10 | 2018-07-19 | 株式会社カネカ | 核酸を含有する検体から核酸を分離する方法及びそのための装置 |
| US20200041449A1 (en) * | 2016-10-04 | 2020-02-06 | Sage Science, Inc. | Apparatuses, methods and systems for automated processing of nucleic acids and electrophoretic sample preparation |
| CN111278550B (zh) * | 2017-06-30 | 2023-04-25 | 赛库乐米克斯公司 | 使用热塑性硅石纳米材料进行尺寸选择纯化 |
| CN117500936A (zh) * | 2021-05-06 | 2024-02-02 | 雅培分子公司 | 用于简单样品提取的组合物和方法 |
| US20220372465A1 (en) * | 2021-05-20 | 2022-11-24 | Kryptos Biotechnologies, Inc. | Methods and systems for extracting nucleic acids from a biological sample |
| WO2023034222A1 (en) * | 2021-08-30 | 2023-03-09 | Abbott Molecular Inc. | Selective purification of rna |
| WO2024238645A2 (en) * | 2023-05-16 | 2024-11-21 | Atila Biosystems Incorporated | Penetrable gel in a reaction vessel |
Family Cites Families (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI844027A7 (fi) | 1984-10-12 | 1986-04-13 | Labsystems Oy | Immunologiskt bestaemningsfoerfarande. |
| FI850481A0 (fi) | 1985-02-06 | 1985-02-06 | Labsystems Oy | Foerfarande foer bestaemning av motmedel eller antigener. |
| DE3682502D1 (de) | 1985-08-21 | 1991-12-19 | Biotope Inc | Verfahren und geraete zur trennung, vermischung und bestimmung von komponenten in spezifischen bindungstests. |
| DE3882040T2 (de) | 1987-12-01 | 1993-09-30 | Biotope Inc | Verfahren und vorrichtungen zur durchführung von untersuchungen. |
| US5075430A (en) * | 1988-12-12 | 1991-12-24 | Bio-Rad Laboratories, Inc. | Process for the purification of DNA on diatomaceous earth |
| US5234809A (en) * | 1989-03-23 | 1993-08-10 | Akzo N.V. | Process for isolating nucleic acid |
| NL8900725A (nl) | 1989-03-23 | 1990-10-16 | Az Univ Amsterdam | Werkwijze en combinatie van middelen voor het isoleren van nucleinezuur. |
| US5279936A (en) | 1989-12-22 | 1994-01-18 | Syntex (U.S.A.) Inc. | Method of separation employing magnetic particles and second medium |
| US5465344A (en) * | 1990-08-20 | 1995-11-07 | Matsushita Electric Industrial Co., Ltd. | Microprocessor with dual-port cache memory for reducing penalty of consecutive memory address accesses |
| WO1994026414A1 (en) | 1993-05-17 | 1994-11-24 | Syntex (U.S.A.) Inc. | Reaction container for specific binding assays and method for its use |
| US5637687A (en) * | 1993-08-31 | 1997-06-10 | Wiggins; James C. | Methods and compositions for isolating nucleic acids |
| US5455344A (en) | 1993-09-03 | 1995-10-03 | Fmc Corporation | Agarose compositions for nucleic acid sequencing |
| EP1146049B1 (de) * | 1994-02-11 | 2005-08-17 | Qiagen GmbH | Verfahren zur Trennung von Doppelstrang/Einzelstrangnukleinsäurestrukturen |
| US5646263A (en) | 1994-09-19 | 1997-07-08 | Promega Corporation | High efficiency method for isolating target substances using a multisample separation device |
| US5705628A (en) * | 1994-09-20 | 1998-01-06 | Whitehead Institute For Biomedical Research | DNA purification and isolation using magnetic particles |
| US5580655A (en) * | 1995-03-03 | 1996-12-03 | Dow Corning Corporation | Silica nanoparticles |
| DE19512368A1 (de) | 1995-04-01 | 1996-10-02 | Boehringer Mannheim Gmbh | System zur Freisetzung und Isolierung von Nukleinsäuren |
| DE19520398B4 (de) | 1995-06-08 | 2009-04-16 | Roche Diagnostics Gmbh | Magnetisches Pigment |
| US5856174A (en) | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
| EP0905520B1 (en) | 1997-09-29 | 2008-03-26 | F. Hoffmann-La Roche Ag | Apparatus for separating magnetic particles |
| DE19746874A1 (de) * | 1997-10-23 | 1999-04-29 | Qiagen Gmbh | Verfahren zur Isolierung und Reinigung von Nukleinsäuren an hydrophoben Oberflächen - insbesondere unter Verwendung hydrophober Membranen |
| US6355470B1 (en) * | 1999-09-03 | 2002-03-12 | E. I. Du Pont De Nemours And Company | Genes encoding picric acid degradation |
| SE9904539D0 (sv) * | 1999-12-10 | 1999-12-10 | Alphahelix Ab | Method and device for the handling of samples and reagents |
| JP4907030B2 (ja) | 2000-03-24 | 2012-03-28 | キアゲン ゲゼルシャフト ミット ベシュレンクテル ハフツング | 分子の単離のための多孔性強磁性又はフェリ磁性ガラス粒子 |
| GB0013658D0 (en) | 2000-06-05 | 2000-07-26 | Dynal Asa | Nucleic acid isolation |
| US6413756B2 (en) * | 2000-06-06 | 2002-07-02 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| US6992782B1 (en) * | 2000-09-13 | 2006-01-31 | Canon Kabushiki Kaisha | Scalable vector graphics print driver |
| SG96587A1 (en) * | 2000-11-21 | 2003-06-16 | Nat Inst Of Education Nanyang | Production of stilbenes in transgenic plants and the method of producing thereof |
| US20030083339A1 (en) * | 2001-04-26 | 2003-05-01 | Masaaki Tamura | Compositions and methods for treating colorectal polyps and cancer |
| ATE519803T1 (de) * | 2001-06-29 | 2011-08-15 | Nanomics Biosystems Pty Ltd | Synthese und verwendung von organosilica-teilchen |
| EP1434571B1 (en) * | 2001-10-05 | 2005-05-11 | SurModics, Inc. | Particle immobilized coatings and uses thereof |
| AU2003202026A1 (en) * | 2002-01-16 | 2003-09-02 | Dynal Biotech Asa | Method for isolating nucleic acids and protein from a single sample |
| JP4080798B2 (ja) * | 2002-06-27 | 2008-04-23 | 日立マクセル株式会社 | 核酸結合用磁性担体およびその製造方法 |
| EP1534850B1 (en) * | 2002-09-03 | 2009-10-28 | Quanta Biosciences, Inc. | Improved compositions and methods for cdna synthesis |
| US7601491B2 (en) | 2003-02-06 | 2009-10-13 | Becton, Dickinson And Company | Pretreatment method for extraction of nucleic acid from biological samples and kits therefor |
| US7025864B2 (en) * | 2003-03-10 | 2006-04-11 | Elchrom Scientific A.G. | Method and apparatus for recovering target molecules from a gel containing said target molecules |
| FR2855822B1 (fr) * | 2003-06-05 | 2005-07-22 | Univ Grenoble 1 | Acides nucleiques en tant que nouveaux selecteurs chiraux specifiques |
| DE10331107B3 (de) | 2003-07-04 | 2004-12-02 | Epigenomics Ag | Verfahren zum Nachweis von Cytosin-Methylierungen in DNA mittels Cytidin-Deaminasen |
| US20050059024A1 (en) * | 2003-07-25 | 2005-03-17 | Ambion, Inc. | Methods and compositions for isolating small RNA molecules |
| EP1510577A1 (en) | 2003-08-29 | 2005-03-02 | Qiagen GmbH | Method for magnetic bead isolation of nucleic acids |
| US20050208037A1 (en) * | 2003-10-21 | 2005-09-22 | Board Of Regents, The University Of Texas System | Thioredoxin increases redox-cycling of anticancer agents thereby sensitizes cancer cells to apoptosis |
| US7947345B2 (en) * | 2003-11-07 | 2011-05-24 | Hewlett-Packard Development Company, L.P. | Synthesis of poly(ethylene amine) on an oxide support |
| US20050106577A1 (en) * | 2003-11-17 | 2005-05-19 | Hashem Akhavan-Tafti | Cleavable solid phases for isolating nucleic acids |
| ATE471212T1 (de) | 2004-01-23 | 2010-07-15 | Qiagen Gmbh | Kontaminationsbarriere |
| US8426126B2 (en) * | 2004-03-18 | 2013-04-23 | Applied Biosystems, Llc | Modified surfaces as solid supports for nucleic acid purification |
| US20050287593A1 (en) * | 2004-05-03 | 2005-12-29 | Schering Corporation | Use of cytokine expression to predict skin inflammation; methods of treatment |
| EP2418018B1 (en) | 2004-12-23 | 2013-05-22 | Abbott Point of Care Inc. | Methods for the separation nucleic acids |
| DE602006016859D1 (de) * | 2005-12-14 | 2010-10-21 | Roche Diagnostics Gmbh | Neues verfahren für die bisulfitbehandlung |
| US7799534B2 (en) * | 2006-05-09 | 2010-09-21 | Beckman Coulter, Inc. | Nonseparation assay methods |
| WO2008051985A2 (en) * | 2006-10-23 | 2008-05-02 | Oregon Health & Science University | Method for separation and identification of biomolecules using unconventional gel electrophoresis and detection of single nanoparticle probes |
| WO2009020609A2 (en) * | 2007-08-06 | 2009-02-12 | Nanogen, Inc. | Isolation of nucleic acids molecules using modified solid supports |
| WO2009117167A1 (en) * | 2008-01-02 | 2009-09-24 | Blood Cell Storage, Inc. | Devices and processes for nucleic acid extraction |
| US8669079B2 (en) * | 2008-11-12 | 2014-03-11 | Cara Therapeutics, Inc. | Methods for genetic analysis of textiles made of Gossypium barbadense and Gossypium hirsutum cotton |
| EP2373996A2 (en) * | 2008-12-05 | 2011-10-12 | Nanoivd, Inc. | Microfluidic-based lab-on-a-test card for a point-of-care analyzer |
| DE102008061714A1 (de) * | 2008-12-12 | 2010-06-17 | Siemens Healthcare Diagnostics Inc., Deerfield | Verfahren zur Aufreinigung von Nukleinsäuren, inbesondere aus fixiertem Gewebe |
| US20110039267A1 (en) * | 2009-08-13 | 2011-02-17 | Cha-Mei Tang | Sample Preparation And Detection Of Analytes Using Silica Beads |
| US20110097723A1 (en) * | 2009-09-19 | 2011-04-28 | Qun Liu | Methods and reagents for analyte detection |
| US8536322B2 (en) * | 2009-10-19 | 2013-09-17 | Zhiqiang Han | Method for nucleic acid isolation by solid phase reversible binding of nucleic acids |
| FR2952368B1 (fr) * | 2009-11-10 | 2012-01-13 | Commissariat Energie Atomique | Particule de silice incorporant une molecule d'interet, son procede de preparation et ses utilisations. |
| JP5528231B2 (ja) * | 2010-06-28 | 2014-06-25 | キヤノン株式会社 | 画像形成装置 |
| WO2012061726A2 (en) * | 2010-11-05 | 2012-05-10 | University Of Utah Research Foundation | Compositions and methods for sequencing dna |
| WO2012086243A1 (ja) * | 2010-12-21 | 2012-06-28 | 株式会社 島津製作所 | 管内で対象成分を操作するためのデバイス及び方法 |
| US20120208026A1 (en) * | 2011-02-10 | 2012-08-16 | Xerox Corporation | Silica-Coated Magnetic Nanoparticles and Process for Making Same |
| US20150122652A1 (en) * | 2011-07-19 | 2015-05-07 | Tennessee Technological University | Nanocomposite polymer hydrogel with aligned nanoparticles |
| US9353409B2 (en) * | 2013-01-15 | 2016-05-31 | Jun Euihum Lee | Compositions and methods for RT-PCR |
| EP3828284A1 (en) * | 2013-03-15 | 2021-06-02 | Abbott Molecular Inc. | One-step procedure for the purification of nucleic acids |
| US8734364B1 (en) * | 2013-11-07 | 2014-05-27 | Genetic Technologies Limited | Device and method for obtaining a biological sample |
-
2014
- 2014-03-14 EP EP20216686.4A patent/EP3828284A1/en not_active Withdrawn
- 2014-03-14 JP JP2016502811A patent/JP6431522B2/ja not_active Expired - Fee Related
- 2014-03-14 US US14/212,880 patent/US9803230B2/en active Active
- 2014-03-14 EP EP14765295.2A patent/EP2969140B1/en active Active
- 2014-03-14 WO PCT/US2014/028518 patent/WO2014144209A1/en not_active Ceased
- 2014-03-14 ES ES14765295T patent/ES2865124T3/es active Active
- 2014-03-14 CN CN201480014153.XA patent/CN105120986B/zh not_active Expired - Fee Related
-
2017
- 2017-08-24 US US15/685,296 patent/US20180010168A1/en not_active Abandoned
-
2018
- 2018-07-19 JP JP2018135643A patent/JP6684868B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN105120986A (zh) | 2015-12-02 |
| US9803230B2 (en) | 2017-10-31 |
| US20180010168A1 (en) | 2018-01-11 |
| EP2969140A1 (en) | 2016-01-20 |
| JP2016514453A (ja) | 2016-05-23 |
| CN105120986B (zh) | 2019-03-12 |
| EP2969140B1 (en) | 2021-02-17 |
| US20140272944A1 (en) | 2014-09-18 |
| EP2969140A4 (en) | 2017-05-03 |
| WO2014144209A4 (en) | 2014-11-20 |
| EP3828284A1 (en) | 2021-06-02 |
| WO2014144209A1 (en) | 2014-09-18 |
| WO2014144209A8 (en) | 2014-10-16 |
| JP6431522B2 (ja) | 2018-11-28 |
| JP6684868B2 (ja) | 2020-04-22 |
| JP2018198599A (ja) | 2018-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2865124T3 (es) | Procedimiento en una etapa para la purificación de ácidos nuncleicos | |
| ES2535809T3 (es) | Métodos para aislar ácidos nucleicos | |
| US7183002B2 (en) | Porous ferro- or ferrimagnetic glass particles for isolating molecules | |
| JP2965131B2 (ja) | 核酸結合用磁性担体およびそれを用いる核酸単離方法 | |
| US9464316B2 (en) | Method for isolating nucleic acids comprising the use of ethylene glycol multimers | |
| ES2877602T3 (es) | Materiales de captura de polinucleótidos y procedimientos de uso de los mismos | |
| US8202693B2 (en) | Method of isolation of nucleic acids | |
| US20020106686A1 (en) | Methods and reagents for the isolation of nucleic acids | |
| JP3818416B2 (ja) | 粒子担体を使用した核酸の抽出方法 | |
| CN105349404A (zh) | 纯化核酸、特别是来自固定组织的核酸的方法 | |
| US11702648B2 (en) | Process for concentrating cells from a sample and then isolating nucleic acids from said cells | |
| WO2008141203A1 (en) | Methods and systems for differential extraction | |
| JP2006508667A (ja) | 磁性ベースの核酸増幅 | |
| WO2009040444A1 (en) | Rna isolation method | |
| ES2350291T3 (es) | Método para aislar ácidos nucleicos que comprende el uso de multímeros de etilenglicol. | |
| JP2006527993A (ja) | クリーンアップビーズ | |
| Fotouhi | Study of microtip-based extraction and purification of DNA from human samples for portable devices | |
| CZ23748U1 (cs) | Sestava pro selektivní izolaci a analýzu látek z biologických vzorků |